Variant report
Variant | esv1007902 |
---|---|
Chromosome Location | chr8:47528660-47562706 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:139)
- CpG islands (count:183)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr8:47529231-47529761 | K562 | blood: | n/a | n/a |
2 | ATF1 | chr8:47548283-47548344 | K562 | blood: | n/a | n/a |
3 | ATF1 | chr8:47551373-47551428 | K562 | blood: | n/a | n/a |
4 | ATF3 | chr8:47529101-47529363 | K562 | blood: | n/a | n/a |
5 | BACH1 | chr8:47536608-47536724 | K562 | blood: | n/a | n/a |
6 | BHLHE40 | chr8:47528443-47529576 | K562 | blood: | n/a | chr8:47528874-47528890 chr8:47529336-47529352 |
7 | CBX3 | chr8:47529072-47529420 | K562 | blood: | n/a | n/a |
8 | CCNT2 | chr8:47528797-47529481 | K562 | blood: | n/a | n/a |
9 | CEBPB | chr8:47529169-47529350 | K562 | blood: | n/a | n/a |
10 | CEBPB | chr8:47534167-47534483 | HepG2 | liver: | n/a | n/a |
11 | CEBPB | chr8:47534139-47534510 | IMR90 | lung: | n/a | n/a |
12 | CEBPB | chr8:47562313-47562722 | HepG2 | liver: | n/a | chr8:47562536-47562547 |
13 | CEBPB | chr8:47562442-47562621 | K562 | blood: | n/a | chr8:47562536-47562547 |
14 | CEBPB | chr8:47557988-47558287 | MCF-7 | breast: | n/a | chr8:47558092-47558103 |
15 | CEBPB | chr8:47554891-47555151 | K562 | blood: | n/a | n/a |
16 | CEBPB | chr8:47549830-47550230 | MCF-7 | breast: | n/a | n/a |
17 | CEBPB | chr8:47534171-47534437 | A549 | lung: | n/a | n/a |
18 | CEBPB | chr8:47554849-47555188 | MCF-7 | breast: | n/a | n/a |
19 | CEBPB | chr8:47546616-47546808 | K562 | blood: | n/a | chr8:47546682-47546693 |
20 | CEBPB | chr8:47548637-47548787 | HepG2 | liver: | n/a | chr8:47548763-47548774 |
21 | CEBPB | chr8:47554881-47555207 | Hela-S3 | cervix: | n/a | n/a |
22 | CEBPB | chr8:47549388-47550184 | HepG2 | liver: | n/a | n/a |
23 | CEBPB | chr8:47530129-47530132 | K562 | blood: | n/a | n/a |
24 | CEBPB | chr8:47540841-47541021 | HepG2 | liver: | n/a | chr8:47540937-47540948 |
25 | CEBPB | chr8:47562301-47562634 | A549 | lung: | n/a | chr8:47562536-47562547 |
26 | CEBPB | chr8:47546537-47546824 | A549 | lung: | n/a | chr8:47546682-47546693 |
27 | CEBPB | chr8:47557913-47558274 | K562 | blood: | n/a | chr8:47558092-47558103 |
28 | CEBPB | chr8:47561061-47561097 | HepG2 | liver: | n/a | n/a |
29 | CEBPB | chr8:47557908-47558267 | HepG2 | liver: | n/a | chr8:47558092-47558103 |
30 | CEBPB | chr8:47557998-47558160 | K562 | blood: | n/a | chr8:47558092-47558103 |
31 | CEBPB | chr8:47529077-47529452 | K562 | blood: | n/a | n/a |
32 | CEBPB | chr8:47557928-47558275 | A549 | lung: | n/a | chr8:47558092-47558103 |
33 | CEBPB | chr8:47552473-47553612 | HepG2 | liver: | n/a | n/a |
34 | CEBPB | chr8:47529068-47529484 | K562 | blood: | n/a | n/a |
35 | CEBPB | chr8:47529073-47529534 | MCF-7 | breast: | n/a | n/a |
36 | CEBPB | chr8:47546529-47547110 | HepG2 | liver: | n/a | chr8:47546682-47546693 |
37 | CEBPB | chr8:47554880-47555156 | HepG2 | liver: | n/a | n/a |
38 | CEBPB | chr8:47546527-47547003 | IMR90 | lung: | n/a | chr8:47546682-47546693 |
39 | CEBPB | chr8:47557878-47558315 | MCF-7 | breast: | n/a | chr8:47558092-47558103 |
40 | CEBPB | chr8:47534198-47534462 | K562 | blood: | n/a | n/a |
41 | CEBPB | chr8:47554606-47555182 | A549 | lung: | n/a | n/a |
42 | CEBPB | chr8:47557938-47558285 | IMR90 | lung: | n/a | chr8:47558092-47558103 |
43 | CEBPB | chr8:47554887-47555177 | K562 | blood: | n/a | n/a |
44 | CEBPB | chr8:47549465-47550234 | IMR90 | lung: | n/a | n/a |
45 | CEBPB | chr8:47548607-47548874 | A549 | lung: | n/a | chr8:47548763-47548774 |
46 | CEBPB | chr8:47552480-47553588 | A549 | lung: | n/a | n/a |
47 | CEBPB | chr8:47547969-47548257 | HepG2 | liver: | n/a | n/a |
48 | CEBPB | chr8:47560585-47560829 | HepG2 | liver: | n/a | n/a |
49 | CEBPB | chr8:47550037-47550193 | K562 | blood: | n/a | n/a |
50 | CEBPB | chr8:47549385-47550207 | A549 | lung: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:47529545-47529595 | HRCEpiC | kidney: | n/a |
2 | chr8:47529015-47529065 | NH-A | brain: | n/a |
3 | chr8:47529545-47529595 | SK-N-SH_RA | brain: | n/a |
4 | chr8:47529545-47529595 | NB4 | blood: | n/a |
5 | chr8:47529545-47529595 | NH-A | brain: | n/a |
6 | chr8:47529015-47529065 | HepG2 | liver: | n/a |
7 | chr8:47529280-47529330 | HNPCEpiC | eye: | n/a |
8 | chr8:47529545-47529595 | HMEC | breast: | n/a |
9 | chr8:47529015-47529065 | HCM | heart: | n/a |
10 | chr8:47529545-47529595 | SK-N-MC | brain: | n/a |
11 | chr8:47529545-47529595 | ECC-1 | luminal epithelium: | n/a |
12 | chr8:47529545-47529595 | HEK293 | kidney: | embryo |
13 | chr8:47529015-47529065 | U87 | brain: | n/a |
14 | chr8:47529015-47529065 | NB4 | blood: | n/a |
15 | chr8:47529545-47529595 | PANC-1 | pancreas: | n/a |
16 | chr8:47529280-47529330 | AG10803 | skin: | n/a |
17 | chr8:47529280-47529330 | SK-N-SH_RA | brain: | n/a |
18 | chr8:47529545-47529595 | HL-60 | blood: | n/a |
19 | chr8:47529545-47529595 | NHDF-neo | bronchial: | n/a |
20 | chr8:47529280-47529330 | MCF-7 | breast: | n/a |
21 | chr8:47529280-47529330 | U87 | brain: | n/a |
22 | chr8:47529545-47529595 | Jurkat | blood: | n/a |
23 | chr8:47529280-47529330 | RPTEC | kidney: | n/a |
24 | chr8:47529280-47529330 | Caco-2 | colon: | n/a |
25 | chr8:47529015-47529065 | H1-hESC | embryonic stem cell: | embryo |
26 | chr8:47529015-47529065 | HPAEpiC | pulmonary alveolar: | n/a |
27 | chr8:47529280-47529330 | HRCEpiC | kidney: | n/a |
28 | chr8:47529545-47529595 | HCM | heart: | n/a |
29 | chr8:47529280-47529330 | GM19239 | blood: | n/a |
30 | chr8:47529545-47529595 | HUVEC | blood vessel: | n/a |
31 | chr8:47529545-47529595 | SAEC | small airway: | n/a |
32 | chr8:47529015-47529065 | AG10803 | skin: | n/a |
33 | chr8:47529015-47529065 | HCPEpiC | choroid plexus: | n/a |
34 | chr8:47529280-47529330 | HCF | heart: | n/a |
35 | chr8:47529015-47529065 | HEEpiC | esophagus: | n/a |
36 | chr8:47529015-47529065 | T-47D | breast: | n/a |
37 | chr8:47529545-47529595 | U87 | brain: | n/a |
38 | chr8:47529015-47529065 | Hepatocyte | liver: | n/a |
39 | chr8:47529280-47529330 | PANC-1 | pancreas: | n/a |
40 | chr8:47529545-47529595 | IMR90 | lung: | fetal |
41 | chr8:47529015-47529065 | SKMC | muscle: | n/a |
42 | chr8:47529280-47529330 | HRE | kidney: | n/a |
43 | chr8:47529280-47529330 | HIPEpiC | eye: | n/a |
44 | chr8:47529015-47529065 | AG09309 | skin: | n/a |
45 | chr8:47529545-47529595 | K562 | blood: | n/a |
46 | chr8:47529015-47529065 | SK-N-MC | brain: | n/a |
47 | chr8:47529015-47529065 | HRCEpiC | kidney: | n/a |
48 | chr8:47529545-47529595 | HPAEpiC | pulmonary alveolar: | n/a |
49 | chr8:47529280-47529330 | BJ | skin: | n/a |
50 | chr8:47529015-47529065 | ovcar-3 | ovarian: | n/a |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:47515437..47518605-chr8:47528973..47530959,3 | K562 | blood: | |
2 | chr8:47512649..47514644-chr8:47529072..47530746,2 | K562 | blood: | |
3 | chr8:47528106..47530039-chr8:47536064..47537656,2 | MCF-7 | breast: | |
4 | chr8:47528106..47530039-chr8:47536064..47537656,2 | MCF-7 | breast: | |
5 | chr8:47524927..47529861-chr8:47530508..47536088,6 | K562 | blood: | |
6 | chr7:97501587..97502366-chr8:47529051..47529557,3 | HCT-116 | colon: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ASNSP1 | TF binding region |
ASNSP1 | CpG island |
ENSG00000248498 | chromatin interactions |
ENSG00000070669 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs544993459 | chr8:47528718-47528719 | Active TSS Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs566992467 | chr8:47528723-47528724 | Active TSS Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs565150212 | chr8:47528778-47528779 | Active TSS Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs367755828 | chr8:47528800-47528801 | Active TSS ZNF genes & repeats Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs530625356 | chr8:47528802-47528803 | Active TSS ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs372605522 | chr8:47528804-47528805 | Active TSS ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs560818863 | chr8:47528819-47528820 | Active TSS ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs576115518 | chr8:47528843-47528844 | Active TSS ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs376117734 | chr8:47528859-47528860 | Active TSS ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs555721763 | chr8:47528913-47528914 | Active TSS ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs113229396 | chr8:47528918-47528919 | Active TSS ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs544880535 | chr8:47528943-47528944 | Active TSS ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs140162191 | chr8:47528952-47528953 | Active TSS ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs558382913 | chr8:47529071-47529072 | Bivalent/Poised TSS Active TSS ZNF genes & repeats | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs578116047 | chr8:47529073-47529074 | Bivalent/Poised TSS Active TSS ZNF genes & repeats | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs28416369 | chr8:47529082-47529083 | Bivalent/Poised TSS Active TSS ZNF genes & repeats | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs560598495 | chr8:47529099-47529100 | Bivalent/Poised TSS Active TSS ZNF genes & repeats | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs574166894 | chr8:47529135-47529136 | Bivalent/Poised TSS Active TSS ZNF genes & repeats | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs543084845 | chr8:47529137-47529138 | Bivalent/Poised TSS Active TSS ZNF genes & repeats | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs562736358 | chr8:47529149-47529150 | Bivalent/Poised TSS Active TSS ZNF genes & repeats | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs567461342 | chr8:47529196-47529197 | Bivalent/Poised TSS Active TSS ZNF genes & repeats | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs10090476 | chr8:47529212-47529213 | Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs376793191 | chr8:47529248-47529249 | Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs551398648 | chr8:47529276-47529277 | Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs547097302 | chr8:47529277-47529278 | Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs565154380 | chr8:47529301-47529302 | Active TSS | TF binding regionCpG islandChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs527506840 | chr8:47529358-47529359 | Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs6558274 | chr8:47529371-47529372 | Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs567055454 | chr8:47529433-47529434 | Active TSS Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs190187541 | chr8:47529436-47529437 | Active TSS Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs113326787 | chr8:47529487-47529488 | Active TSS Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs549791688 | chr8:47529495-47529496 | Active TSS Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs569554178 | chr8:47529498-47529499 | Active TSS Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs538588175 | chr8:47529522-47529523 | Active TSS Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs563084689 | chr8:47529528-47529529 | Active TSS Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs146406854 | chr8:47529596-47529597 | Active TSS Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs566777546 | chr8:47529643-47529644 | Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs372177153 | chr8:47529742-47529743 | Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs538989520 | chr8:47529791-47529792 | Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs139456856 | chr8:47529875-47529876 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs552605165 | chr8:47529877-47529878 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs374818004 | chr8:47529923-47529924 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs569489365 | chr8:47529975-47529976 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs576376864 | chr8:47530026-47530027 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs545360905 | chr8:47530030-47530031 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs565059603 | chr8:47530095-47530096 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs527564323 | chr8:47530158-47530159 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs547226969 | chr8:47530159-47530160 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs149674819 | chr8:47530170-47530171 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs145500030 | chr8:47530186-47530187 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Oral cancer | 21386901 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Lung cancer | 18438408 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cancer | 20164920 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 20409316 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:47527000-47529400 | Active TSS | K562 | blood |
2 | chr8:47528200-47529200 | Active TSS | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
3 | chr8:47528200-47529200 | Active TSS | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
4 | chr8:47528600-47528800 | Bivalent/Poised TSS | Skeletal Muscle Male | skeletal muscle |
5 | chr8:47528600-47529400 | Active TSS | Pancreas | Pancrea |
6 | chr8:47528800-47529200 | ZNF genes & repeats | Placenta | Placenta |
7 | chr8:47529000-47529200 | Bivalent/Poised TSS | ES-I3 Cell Line | embryonic stem cell |
8 | chr8:47529200-47529600 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
9 | chr8:47529400-47529800 | Flanking Active TSS | K562 | blood |
10 | chr8:47529400-47531400 | Weak transcription | Pancreas | Pancrea |
11 | chr8:47529800-47531000 | Enhancers | K562 | blood |
12 | chr8:47531600-47535200 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
13 | chr8:47531800-47532200 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
14 | chr8:47534800-47535200 | Enhancers | Skeletal Muscle Male | skeletal muscle |
15 | chr8:47539400-47539800 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
16 | chr8:47547400-47549400 | Enhancers | Skeletal Muscle Female | skeletal muscle |
17 | chr8:47547400-47549600 | Enhancers | Skeletal Muscle Male | skeletal muscle |
18 | chr8:47548000-47549200 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
19 | chr8:47549400-47554800 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
20 | chr8:47549600-47555000 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
21 | chr8:47554800-47555600 | Enhancers | Skeletal Muscle Female | skeletal muscle |
22 | chr8:47555000-47556600 | Enhancers | Skeletal Muscle Male | skeletal muscle |
23 | chr8:47555600-47560600 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
24 | chr8:47556600-47560600 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
25 | chr8:47560600-47564400 | Enhancers | Skeletal Muscle Male | skeletal muscle |
26 | chr8:47560600-47564400 | Enhancers | Skeletal Muscle Female | skeletal muscle |